Recently, NMN (nicotinamide mononucleotide) has seen significant investment interest but faces controversy due to regulatory tightening. Globally, Japan was the first to approve NMN as a food ingredient, but in Australia, it is only allowed for export. In the US, the FDA reclassified NMN as a drug, causing a market downturn.
As NMN’s popularity wanes, ergothioneine has emerged. Discovered in 1909 in the fungus Claviceps purpurea, it is a powerful natural antioxidant with unique absorption mechanisms. Prominent scientists, like Barry Halliwell from the National University of Singapore, have extensively studied ergothioneine. It has over 10,000 patents and numerous clinical trials, earning it the nickname “longevity vitamin.”
Ergothioneine, used in both cosmetics and food, offers anti-aging, whitening, anti-inflammatory, and repair benefits.
We also recognizes its potential and has been actively researching and developing ergothioneine-based products.
In health products, ergothioneine offers anti-aging, lifespan extension, cognitive enhancement, eye protection, liver protection, and post-exercise recovery benefits. Studies by Makoto Katsube and Yukio Kato showed that supplementing mice with ergothioneine increased their median lifespan by 16% and improved their overall health.
Ergothioneine also enhances telomerase activity, protecting and extending telomere length, which is crucial for cell health and longevity. Research by Priscilla Samuel in 2022 confirmed its benefits in reducing telomere shortening under oxidative stress conditions.
Ergothioneine plays a significant role in preventing elderly diseases, such as respiratory, neurological, digestive, cardiovascular, endocrine, and skin diseases. With China’s aging population, promoting healthy aging could reduce social burdens and create value.
Studies show that ergothioneine not only shares similar functions with NMN, such as promoting energy metabolism, but also outperforms NMN in anti-aging and antioxidant aspects. Approved as a food ingredient in the US, Europe, Canada, Australia, and Japan, China’s National Health Commission accepted its new food ingredient application in May 2024.
Xi’an springjia Bio-technique Co.,Ltd plans to leverage this approval to expand their product range with ergothioneine-based supplements and skincare products. The beauty economy and health industry are rapidly growing, and ergothioneine’s market potential is immense. According to Early Data, the oral beauty market for ergothioneine grew by 6980% in 2023. With advancements in production and regulatory breakthroughs, ergothioneine is set to become the next “super star” in the anti-aging field.
Xi’an springjia Bio-tech remains at the forefront of ergothioneine innovation, committed to delivering its numerous health benefits to consumers worldwide.